EPIDAUROS Biotechnologie AG

EPIDAUROS' started with the mission to optimally tailor drugs to the individual patients' genetic profiles, pharmacogenomics. The pharmacogenetic tests developed by EPIDAUROS make it possible for the individual patient to receive the right drug regimen and the optimal dosage.
EPIDAUROS focuses on three complementary business areas. The pharmacogenetic tests developed in the business area of Diagnostics are used as the basis for EPIDAUROS' other business areas, Support and Pharma.

Activity:

- Manufacturing

Product / Technology type(s) covered:

- Bio
- Diagnostics
- Pharmaceuticals / Therapeutics
- Technology

Therapeutic targets:

- Genetics

Markets Covered

a. HeadQuarter: Germany

b. Continent(s) active: Europe , North America

c. Countries active:

Corporate data:

Number of Employees: 61

Turnover:

Amount:	Year:	Currency:
1100000	2001	Euro

Year founded: 1997